Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Current issues in dose-finding designs: A response to the US Food and Drug Adminstration’s Oncology Center of Excellence Project Optimus

Clinical Trials(2024)10.1177/17407745241234652Source: DataRank Database

Current issues in dose-finding designs: A response to the US Food and Drug Adminstration’s Oncology Center of Excellence Project Optimus is a research paper published in Clinical Trials (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 3.86)OA: greenTopics (45)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Elizabeth Garrett‐Mayer ORCID,Nolan A. Wages ORCID,Susan Halabi ORCID,Ying Kuen Cheung ORCID,Peter F. Thall ORCID

Live enrichment

PubMed:38570906 OpenAlex:https://openalex.org/W4393946324

Clinical Center

Grant: 1R01CA261978

Clinical Center

Grant: P30 CA016672

Clinical Center

Grant: R01CA247932

NCI NIH HHS

Grant: R01 CA261978

NCI NIH HHS

Grant: R21 CA263950

NCI NIH HHS

Grant: R01 CA256157

NCI NIH HHS

Grant: R01 CA249279

FWCI

3.86

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: https://journals.sagepub.com/page/policies/text-and-data-mining-license

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11132935/pdf/nihms-1965971.pdf

publisherhttps://journals.sagepub.com/doi/pdf/10.1177/17407745241234652

publisherhttps://journals.sagepub.com/doi/full-xml/10.1177/17407745241234652

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11132935

Fields of Study

Statistical Methods in Clinical TrialsAdvanced Radiotherapy TechniquesCancer Genomics and DiagnosticsHumansUnited StatesUnited States Food and Drug AdministrationResearch DesignAntineoplastic AgentsDose-Response Relationship, DrugNeoplasmsMedical OncologyMaximum Tolerated DoseClinical Trials, Phase I as TopicDrug Development

MeSH Terms

Drug DevelopmentAntineoplastic AgentsDose-Response Relationship, DrugHumansMedical OncologyNeoplasmsResearch DesignUnited StatesUnited States Food and Drug AdministrationClinical Trials, Phase I as TopicMaximum Tolerated Dose

Keywords

Center of excellenceExcellenceFood and drug administrationMedicineMedical physicsCurrent (fluid)Center (category theory)OncologyInternal medicinePharmacologyComputer scienceEngineeringPolitical scienceDatabaseElectrical engineeringDose findingdose optimizationdrug developmentphase Itrial design